Paula Ragan, X4 Pharmaceuticals CEO
Small Massachusetts biotech tries to beat back the bears with $55M PIPE
As the bear market continues to hold down biotechs of several shapes and sizes, one company is selling shares to extend its runway.
Boston-based X4 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
